Northwest & Ethical Investments’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663K | Buy |
39,579
+3,900
| +11% | +$65.4K | 0.02% | 374 |
|
|
2025
Q1 | $548K | Buy |
35,679
+21,479
| +151% | +$330K | 0.01% | 382 |
|
|
2024
Q4 | $313K | Buy |
14,200
+4,200
| +42% | +$92.5K | 0.01% | 369 |
|
|
2024
Q3 | $180K | Buy |
10,000
+5,200
| +108% | +$93.7K | ﹤0.01% | 429 |
|
|
2024
Q2 | $78K | Buy |
+4,800
| New | +$78K | ﹤0.01% | 460 |
|
|
2018
Q4 | – | Sell |
-110,931
| Closed | -$2.39M | – | 404 |
|
|
2018
Q3 | $2.39M | Buy |
+110,931
| New | +$2.39M | 0.15% | 202 |
|
|
2017
Q2 | – | Sell |
-13,960
| Closed | -$448K | – | 396 |
|
|
2017
Q1 | $448K | Sell |
13,960
-41,344
| -75% | -$1.33M | 0.03% | 330 |
|
|
2016
Q4 | $2M | Buy |
55,304
+15,340
| +38% | +$556K | 0.14% | 182 |
|
|
2016
Q3 | $1.84M | Buy |
+39,964
| New | +$1.84M | 0.13% | 176 |
|
|
2013
Q3 | – | Sell |
-26,709
| Closed | -$1.05M | – | 238 |
|
|
2013
Q2 | $1.05M | Buy |
+26,709
| New | +$1.05M | 0.08% | 181 |
|